Dexrazoxane for protection against cardiotoxic effects of anthracyclines.
Sehested
M
M
Holm
B
B
Jensen
P B
PB
D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D004250:DNA Topoisomerases, Type II / Q000187:drug effects*; D006801:Humans; D011929:Razoxane / Q000627:therapeutic use*
D000903:Antibiotics, Antineoplastic; D002317:Cardiovascular Agents; D011929:Razoxane; D004250:DNA Topoisomerases, Type II